NASDAQ:KROS

Keros Therapeutics Inc [KROS] Revenue clocked in at $232.84 million, down -75.76% YTD: What’s Next?
Caleb Clifford
Keros Therapeutics Inc [NASDAQ: KROS] closed the trading session at $14.49 on 2025-10-15. The day’s price range saw the stock ...